Multi-Center Prospective Evaluation of Complex Adult Spinal Deformity Surgery (CADS)
The goal of this study is to evaluate surgical treatment outcomes of complex adult spinal deformity patients, including radiographic and clinical outcomes, surgical and postoperative complications, risk factors for revisions, rates of revision surgery over an extended time period (10 years follow-up). Imaging studies and HRQoLs will be used as part of the review of patients. Further assessments regarding opioid use and patient outcomes will also be made.
Multi-center Prospective Single Position Spine Surgery Outcomes Registry
The purpose of this study is to systematically, prospectively compare fusion techniques for thoracolumbar spinal fusion patients and assess long-term patient outcomes and revision rates.
Multi-ethnic Observational Study of American Asian and Pacific Islander Communities
The purpose of this research study is to enroll 10,000 participants from Asian, Native Hawaiian, and Pacific Islander (AsA-NHPI) communities across the United States. This study will provide new insights into important health conditions and risk factors affecting these communities.
Multicenter Adaptive Randomized Controlled Trial Platform To Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized Patients with Respiratory Infections(STRIVE)
We are studying an investigational drug for treatment of people in the hospital with COVID-19. This drug is investigational because it can only be used for research in hospitalized participants. This study drug is approved in Japan to treat COVID-19 only for outpatients (those not hospitalized). It is not approved by the U.S. Food and Drug Administration (FDA) or any other national government agency. We are trying to find out if this investigational drug is effective when given in addition to the current standard treatment for COVID-19. We are also trying to make sure it is safe for people who are sick in the hospital to take.
Multicenter Prospective Collaborative Study of Surgical Outcomes in Patients with Neuro-endocrine Tumors
Primary aims of this research include 1) investigate and establish outcomes benchmarks, such as disease remission rates and quality of life, 2) explore the variability in care across the country, 3) assess risk factors for complications including unplanned hospital readmission, 4) explore health economics such as costs of care and mitigation strategies, and 5) develop risk-assessment tools.
Multicenter Randomized Pragmatic Clinical Trial Comparing Two- Versus Three-Antibiotic Therapy for Pulmonary Mycobacterium avium Complex Disease
To determine whether 2-drug is non-inferior to 3-drug (standard) therapy against pulmonary Mycobacterium avium complex (MAC) and whether 2-drug therapy is better tolerated than 3-drug therapy.
Multicenter Study of Epilepsy Surgery Long Term Outcomes Mortality
The Multicenter Study of Epilepsy Surgery – Long Term Outcomes Mortality study aims to examine the various aspects of epilepsy surgery outcomes after more than 10 years since surgery. Patients who enrolled in the original Multicenter Epilepsy Study have been re-identified and now need to be contacted to determine if they would like to participate in a follow-up study. Information that will be obtained by Yale (the main site) will include the number of patients rendered seizure free from surgery, those who suffered from seizure recurrence and those who have passed away after surgery. This information will permit researchers to address questions regarding the stability of seizure freedom and will allow physicians to better treat patients by understanding the factors predictive of good seizure outcome.
Multiparametric Mapping of Knee Joint with Magnetic Resonance Fingerprinting
20 healthy volunteers (18-65 years old) will used in aim2 for evaluation and validation of 3D-MRF pulse sequence 80 participants (40-75 years old) will be recruited for this study for aim3 (40 knee OA patients and 40 healthy controls). All participants will attend one study visit for a baseline MRI, and only the patients will have a follow up visit 2 years after their baseline MRI. A covariance analysis will be performed as well as Pearson and Spearman rank correlation coefficients. Also to get the following two questionnaire filled on visit !.http://www.koos.nu/koos-english.pdfhttp://orthopaedicscore.com/scorepages/knee_injury_osteopaedic_outcome_score_womac.html
Multiple Myeloma | NYU Langone Health
Perlmutter Cancer Center doctors use the newest medical therapies to treat multiple myeloma, a cancer of the blood cells.
Multiple Sclerosis | NYU Langone Health
Specialists at NYU Langone are experts at diagnosing and treating multiple sclerosis, or MS, a chronic disease of the central nervous system.